On October 5 and 6, 2026, scientists, doctors, and researchers will gather at Harvard Medical School for an important conference on biomarkers of aging. Biomarkers are measurable indicators in the body that can indicate biological age, often more accurately than the calendar age. This meeting focuses on developing and improving these measurement methods to better understand the aging process.
The goal of the conference is, among other things, to find reliable and standardized methods that researchers can use to measure whether treatments actually slow down aging. This is important because new therapies are becoming increasingly closer to influencing the aging process itself. This way, they can contribute to a healthier and longer life.
During the congress, various topics will be discussed, such as the use of artificial intelligence, the analysis of cells and the immune system. There will also be attention paid to the ethical aspects of measuring aging and applying this knowledge in practice. In addition to lectures, there will also be presentations of research, and there will be space for exchange between experts.
The Biomarkers of Aging Consortium, an international group of more than fifty institutions, organizes this annual conference. They are committed to developing scientifically based and recognized measurement instruments that can be applied in clinical practice and research. In this way, they aim to contribute to the progress in aging research worldwide.
These developments are of great importance for anyone interested in healthy aging. Reliable measurement methods make it possible to improve treatments specifically to increase the quality of life in old age.
Source: Press release
